Effectiveness of Nicotine Replacement Therapy and Behavioral Intervention in Tobacco Cessation-A Tertiary Hospital-Based Randomized Controlled Trial.

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

Who Took Part

By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.

How the Study Was Run

The design is described as randomized, open-label and parallel-group.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Being open-label, the Therapeutic nicotine (patch, non-peptide) study did not mask who received what.

The Therapeutic nicotine (patch, non-peptide) group and the comparison group ran side by side rather than switching.

This 1.5-year prospective, open-label, three-arm parallel-group randomized controlled trial was conducted at the Tobacco Cessation Clinic, SCB Dental College and Hospital, Odisha, India.

The three intervention groups-BI, BI + nicotine patch, and BI + nicotine gum-were assessed using a prevalidated proforma on sociodemographics, relevant medical and dental history, oral hygiene practices, and previous tobacco use patterns.

What Was Measured

The subject headings attached to it are Tobacco Use Cessation Devices, India, Behavior Therapy, Tertiary Care Centers, Smoking Cessation, Tobacco Use Cessation and Tobacco, Smokeless.

Author keywords: Behavioral counseling, Fagerstrom test, nicotine, nicotine replacement therapy and smokeless tobacco.

What This Means in Plain Language

The paper is a randomized, open-label and parallel-group study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 9 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2025 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.